- Merck & Co. (Rahway, NJ)
- …and accountable for the end-to-end lifecycle management for our company's late - stage multi-tumor assets. This includes the breadth/depth of development ... launches. The Vice President (VP) will work collaboratively with Oncology VP TA heads directly as well as through...of Asset Team Leads who will develop individual molecule late - stage development plans; will work across TA… more
- Merck & Co. (Rahway, NJ)
- …human health.This position supports statistical programming activities for multiple and/or late stage drug/vaccine clinical development projects. ... tables, listings, figures), the span of which range from individual clinical trials to world-wide regulatory application submissions and post marketing support.The… more
- Merck & Co. (Rahway, NJ)
- …mechanistic PK-PD models and QSP models for decision making in early and/or late - stage clinical development Experience with mechanistic modeling for antibody ... to clinical pharmacology, mechanistic PK-PD modeling and pharmacometrics of oncology drugs from post-PCC to registration. Directors are leaders in the field… more
- Pfizer (New York, NY)
- … trial(s) in support of the development strategy for programs within the Late - Stage Oncology portfolio. **Position Responsibilities** + Maintains current ... scientific and clinical knowledge in the specific therapeutic and disease area(s)... Research experience in the Phase 3/pivotal space in Oncology , ideally on the side of the sponsor. +… more
- Merck (Rahway, NJ)
- …and accountable for the end-to-end lifecycle management for our company's late - stage multi-tumor assets. This includes the breadth/depth of development ... launches. The Vice President (VP) will work collaboratively with Oncology VP TA heads directly as well as through...of Asset Team Leads who will develop individual molecule late - stage development plans; will work across TA… more
- Merck (Rahway, NJ)
- …mechanistic PK-PD models and QSP models for decision making in early and/or late - stage clinical development + Experience with mechanistic modeling for ... to clinical pharmacology, mechanistic PK-PD modeling and pharmacometrics of oncology drugs from post-PCC to registration. Directors are leaders in the field… more
- Merck (Rahway, NJ)
- …health. This position supports statistical programming activities for multiple and/or late stage drug/vaccine clinical development projects. Accountability ... tables, listings, figures), the span of which range from individual clinical trials to world-wide regulatory application submissions and post marketing support.… more
- Sumitomo Pharma (New York, NY)
- …products in the US, Canada, and Europe, and a diverse pipeline of early- to late - stage assets, we aim to accelerate discovery, research, and development to bring ... products in the US, Canada, and Europe, a diverse pipeline of early- to late - stage assets, and in-house advanced technology capabilities, we aim to accelerate… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (New York, NY)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
